Company Filing History:
Years Active: 2019
Title: Innovations in Tumor Treatment by Alessandro Olivi
Introduction
Alessandro Olivi is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of medicine, particularly in the treatment of tumors. His innovative approach focuses on local delivery formulations of acriflavine, which have shown promising results in increasing median survival rates for subjects with proliferative diseases.
Latest Patents
Olivi holds a patent for "Local delivery forms of acriflavine for treating tumors." This patent describes local delivery formulations of the antineoplastic and microbicide agent acriflavine. These formulations are significantly more efficacious at increasing the median survival of subjects compared to systemic administrations of acriflavine. The local delivery formulations demonstrate a dose-dependent increase in median survival, providing enhanced efficacy without the toxicity associated with systemic administration.
Career Highlights
Alessandro Olivi is affiliated with The Johns Hopkins University, where he continues to advance research in tumor treatment. His work has garnered attention for its potential to improve patient outcomes in oncology.
Collaborations
Olivi collaborates with esteemed colleagues such as Henry Brem and Antonella Mangraviti. Their combined expertise contributes to the innovative research being conducted at The Johns Hopkins University.
Conclusion
Alessandro Olivi's contributions to the field of tumor treatment through his innovative patent on acriflavine formulations highlight the importance of local delivery methods in enhancing patient survival rates. His work exemplifies the potential of targeted therapies in modern medicine.